Literature DB >> 2843815

Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia.

D R Collins1, T J Knott, R J Pease, L M Powell, S C Wallis, S Robertson, C R Pullinger, R W Milne, Y L Marcel, S E Humphries.   

Abstract

Familial hypobetalipoproteinaemia is a rare autosomal dominant disorder in which levels of apo-B-containing plasma lipoproteins are approximately half-normal in heterozygotes and virtually absent in homozygotes. Here we describe mutations of the apo-B gene that cause two different truncated variants of apo-B in unrelated individuals with hypobetalipoproteinaemia. One variant, apo-B(His1795----Met-Trp-Leu-Val-Thr-Term) is predicted to be 1799 amino acids long and arises from deletion of a single nucleotide (G) from leucine codon 1794. This protein was found at low levels in very low density and low density lipoprotein fractions in the blood. The second, shorter variant, apo-B(Arg1306----Term), is caused by mutation of a CpG dinucleotide in arginine codon 1306 converting it to a stop codon and predicting a protein of 1305 residues. The product of this allele could not be detected in the circulation. The differences in size and behaviour of these two variants compared to apo-B100 or apo-B48 point to domains that may be important for the assembly, secretion or stability of apo-B-containing lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843815      PMCID: PMC338564          DOI: 10.1093/nar/16.17.8361

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants.

Authors:  L M Kunkel; K D Smith; S H Boyer; D S Borgaonkar; S S Wachtel; O J Miller; W R Breg; H W Jones; J M Rary
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

6.  The content of apolipoprotein B in chylomicron particles.

Authors:  S Bhattacharya; T G Redgrave
Journal:  J Lipid Res       Date:  1981-07       Impact factor: 5.922

Review 7.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

8.  Immunofluorescence studies of apolipoprotein B in intestinal mucosa. Absence in abetalipoproteinemia.

Authors:  R M Glickman; P H Green; R S Lees; S E Lux; A Kilgore
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

9.  Degradation of apolipoprotein B-100 of human plasma low density lipoproteins by tissue and plasma kallikreins.

Authors:  A D Cardin; K R Witt; J Chao; H S Margolius; V H Donaldson; R L Jackson
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

10.  Molecular weights of apoprotein B obtained from human low-density lipoprotein (apoprotein B-PI) and from rat very low density lipoprotein (apoprotein B-PIII).

Authors:  J Elovson; J C Jacobs; V N Schumaker; D L Puppione
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

View more
  19 in total

1.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

Review 2.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  A cholesterol-lowering gene maps to chromosome 13q.

Authors:  H Knoblauch; B Müller-Myhsok; A Busjahn; L Ben Avi; S Bähring; H Baron; S C Heath; R Uhlmann; H D Faulhaber; S Shpitzen; A Aydin; A Reshef; M Rosenthal; O Eliav; A Mühl; A Lowe; D Schurr; D Harats; E Jeschke; Y Friedlander; H Schuster; F C Luft; E Leitersdorf
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 4.  Can modulators of apolipoproteinB biogenesis serve as an alternate target for cholesterol-lowering drugs?

Authors:  Lynley M Doonan; Edward A Fisher; Jeffrey L Brodsky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-04-06       Impact factor: 4.698

5.  Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

Authors:  P J Talmud; J K Lloyd; D P Muller; D R Collins; J Scott; S Humphries
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 6.  Application of the polymerase chain reaction to the diagnosis of human genetic disease.

Authors:  J Reiss; D N Cooper
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

7.  Familial hypobetalipoproteinemia caused by a mutation in the apolipoprotein B gene that results in a truncated species of apolipoprotein B (B-31). A unique mutation that helps to define the portion of the apolipoprotein B molecule required for the formation of buoyant, triglyceride-rich lipoproteins.

Authors:  S G Young; S T Hubl; R S Smith; S M Snyder; J F Terdiman
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

8.  Molecular and metabolic basis for the metabolic disorder normotriglyceridemic abetalipoproteinemia.

Authors:  D A Hardman; C R Pullinger; R L Hamilton; J P Kane; M J Malloy
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

9.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

10.  The human apolipoprotein B 3' hypervariable region: detection of eight new alleles and comparisons of allele frequencies in blacks and whites.

Authors:  J E Hixson; P K Powers; C A McMahan
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.